Innovation Pharmaceuticals Inc (IPIX)

[Blues44]

Reviewing the ClinicalTrials.gov website regarding the Primary Efficacy Endpoint of the Prurisol Phase 2 trial it states, "The primary efficacy endpoint will be the percentage of subjects with (greater than or equal to) 2 point improvement in IGA rating as defined by visual inspections of patient lesions. Time frame: 84 days. This is the percentage of all subjects pooled together vs. placebo.